LITYNDA
LIVE

Serial Number

79190853

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 23, 2016

Add to watchlist:

No watchlists yet
View on USPTO

LITYNDA Trademark

Serial Number: 79190853 • Registration: 5153313

LITYNDA is a trademark filed by NOVARTIS AG on May 23, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 23, 2016

Registration Date

March 7, 2017

Published for Opposition

December 20, 2016

Cancellation Date

June 13, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 8, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jan 8, 2023 DETH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 7, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 8, 2017 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Jun 20, 2017 FICS
FINAL DISPOSITION PROCESSED
Jun 20, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 7, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 7, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 20, 2016 NPUB
PUBLISHED FOR OPPOSITION
Dec 20, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 30, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 5, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 4, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 26, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 26, 2016 REAP
REFUSAL PROCESSED BY IB
Oct 2, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 15, 2016 RFCS
REFUSAL PROCESSED BY MPU
Sep 15, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 14, 2016 RFCR
NON-FINAL ACTION WRITTEN
Sep 13, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 10, 2016 MAFR
ASSIGNED TO EXAMINER
Sep 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 6, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 26, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 25, 2016 SDRC